Home › Uveal Melanoma › Colorado › Denver
Uveal Melanoma clinical trials in Denver, CO
5 studies for Uveal Melanoma are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
RecruitingPhase 1/2
- SCRI Oncology Partners- Denver, Denver
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
RecruitingPhase 1/2
- SCRI - Denver, Denver
Neoadjuvant Darovasertib in Primary Uveal Melanoma
RecruitingPhase 3
- The Melanoma and Skin Cancer Institute, Englewood · 6 mi away
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RecruitingPhase 2/3
- The Melanoma & Skin Cancer Institute, Englewood · 6 mi away
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
RecruitingPhase 1/2
- Sarah Cannon Research Institute (SCRI) - Denver HealthONE Location, Denver
Uveal Melanoma trials in other cities
- Philadelphia, PA7 studies
- Nashville, TN6 studies
- Los Angeles, CA6 studies
- Boston, MA5 studies
- Scottsdale, AZ5 studies
- New York City, NY5 studies
- Houston, TX5 studies
- Columbus, OH5 studies
- Aurora, CO4 studies
- Mountain View, CA4 studies
- Miami, FL4 studies
- Pittsburgh, PA4 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer29 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma27 studies
- Colorectal Cancer23 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Cancer (all types)18 studies
- Ovarian Cancer16 studies
- Lung Cancer16 studies
- Endometrial Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.